Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aanjaay IndustriesBOM:524322 +6.32%34 PB Ratio is 1.93 as of Jul. 26, 2026, which is 14% above its 10-year median of 1.70. GuruFocus rates BOM:524322 with a GF Score™ of 34/100. The stock has 3 warning signs investors should review. Among 925 Drug Manufacturers companies, Aanjaay Industries ranks worse than 51.78% on this metric.
The historical rank and industry rank for Aanjaay Industries's PB Ratio or its related term are showing as below:
BOM:524322'
s PB Ratio Range Over the Past 10 Years
Min: 0.64 Med: 1.7 Max: 7.03
Current: 1.93
During the past 13 years, Aanjaay Industries's highest PB Ratio was 7.03. The lowest was 0.64. And the median was 1.70.
BOM:524322's PB Ratio is ranked worse than 51.78% of 925
companies
in the Drug Manufacturers industry
Industry Median: 1.87
vs BOM:524322: 1.93
During the past 12 months, Aanjaay Industries's average Book Value Per Share Growth Rate was 20.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Aanjaay Industries was 5.40% per year. The lowest was -197.90% per year. And the median was -4.00% per year.
Back to Basics: PB Ratio
Aanjaay Industries (BOM:524322) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Aanjaay Industries PB Ratio Related Terms
Aanjaay Industries PB Ratio Historical Data
* Premium members only.
The historical data trend for Aanjaay Industries's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Aanjaay Industries's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aanjaay Industries PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aanjaay Industries's PB Ratio distribution charts can be found below:
* The bar in red indicates where Aanjaay Industries's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Aanjaay Industries (BOM:524322) has a PB Ratio of 1.93 as of Jul. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Aanjaay Industries and its competitors. This is 14% above median its historical median of 1.70. Over the past decade, Aanjaay Industries' PB Ratio has ranged from 0.64 to 7.03. According to the industry distribution chart, Aanjaay Industries ranks #479 out of 925 companies in the Drug Manufacturers industry, placing it in the top 51.8%.
Is Aanjaay Industries' PB Ratio too high?
Aanjaay Industries' current PB Ratio of 1.93 is 14% above median its 10-year median of 1.70. Over the past 10 years, this metric has ranged from a low of 0.64 to a high of 7.03. The Drug Manufacturers industry median PB Ratio is 1.87. Aanjaay Industries' value of 1.93 is 3.2% above this industry median. Based on the distribution chart, Aanjaay Industries ranks #479 out of 925 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Aanjaay Industries has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Aanjaay Industries' PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Aanjaay Industries ranks #479 out of 925 companies for PB Ratio. This places Aanjaay Industries in the lower half of its industry. The industry median PB Ratio is 1.87. Aanjaay Industries' value of 1.93 is 3.2% above this benchmark. Historically, Aanjaay Industries' own PB Ratio has ranged from 0.64 to 7.03 over the past decade. While the company's 10-year median is 1.70 vs. the industry median of 1.87, Aanjaay Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.87, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aanjaay Industries's current PB Ratio of 1.93 is 3.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Aanjaay Industries and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aanjaay Industries's current PB Ratio is 1.93, which is 14% above median its own 10-year median of 1.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aanjaay Industries stock overvalued right now?
Aanjaay Industries (BOM:524322) has a current PB Ratio of 1.93. The current PB Ratio is 1.93, which is 14% above median its 10-year median of 1.70 and 3.2% above the Drug Manufacturers industry median of 1.87. Aanjaay Industries' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Aanjaay Industries (BOM:524322), the current PB Ratio is 1.93 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kabra Drugs Ltd is an India-based drug manufacturing company. It is engaged in Permaculture manufacturing and trading in pharmaceutical products. Geographically, all the company operations are carried out in India. The company's drug manufacturing plant is located in Madhya Pradesh, India. Its products include Cardiovascular Drugs, Anti-Infective Drugs, Oncology Drugs, Gastrointestinal Drugs, and Hormonal Drugs.
34GF Score
Get the complete analysis for BOM:524322
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524322 has been successfully added to your 
